These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32697863)

  • 21. [Facioscapulohumeral muscular dystrophy type 2].
    Sacconi S; Desnuelle C
    Rev Neurol (Paris); 2013; 169(8-9):564-72. PubMed ID: 23969240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restrictive lung involvement in facioscapulohumeral muscular dystrophy.
    Scully MA; Eichinger KJ; Donlin-Smith CM; Tawil R; Statland JM
    Muscle Nerve; 2014 Nov; 50(5):739-43. PubMed ID: 24639337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy.
    Wang LH; Shaw DWW; Faino A; Budech CB; Lewis LM; Statland J; Eichinger K; Tapscott SJ; Tawil RN; Friedman SD
    BMC Musculoskelet Disord; 2021 Mar; 22(1):262. PubMed ID: 33691664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histopathological correlations and fat replacement imaging patterns in recessive limb-girdle muscular dystrophy type 12.
    De Wel B; Huysmans L; Depuydt CE; Goosens V; Peeters R; Santos FP; Thal DR; Dupont P; Maes F; Claeys KG
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1468-1481. PubMed ID: 37078404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.
    Andersen G; Dahlqvist JR; Vissing CR; Heje K; Thomsen C; Vissing J
    J Neurol; 2017 Mar; 264(3):438-447. PubMed ID: 28000006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of muscle MRI in an atypical presentation of FSHD2.
    Jesuthasan A; Shah S; Morrow JM
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32532898
    [No Abstract]   [Full Text] [Related]  

  • 27. Best practice guidelines on genetic diagnostics of facioscapulohumeral muscular dystrophy: Update of the 2012 guidelines.
    Giardina E; Camaño P; Burton-Jones S; Ravenscroft G; Henning F; Magdinier F; van der Stoep N; van der Vliet PJ; Bernard R; Tomaselli PJ; Davis MR; Nishino I; Oflazer P; Race V; Vishnu VY; Williams V; Sobreira CFR; van der Maarel SM; Moore SA; Voermans NC; Lemmers RJLF
    Clin Genet; 2024 Jul; 106(1):13-26. PubMed ID: 38685133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishing the role of muscle ultrasound as an imaging biomarker in facioscapulohumeral muscular dystrophy.
    Vincenten SCC; Teeselink S; Voermans NC; van Engelen BGM; Mul K; van Alfen N
    Neuromuscul Disord; 2023 Dec; 33(12):936-944. PubMed ID: 37968164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscle magnetic resonance imaging in patients with LAMA2-related muscular dystrophy.
    Tan D; Ge L; Fan Y; Wei C; Yang H; Liu A; Xiao J; Xiong H; Zhu Y
    Neuromuscul Disord; 2021 Nov; 31(11):1144-1153. PubMed ID: 34702656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal features of STIR bright signal in FSHD.
    Friedman SD; Poliachik SL; Otto RK; Carter GT; Budech CB; Bird TD; Miller DG; Shaw DW
    Muscle Nerve; 2014 Feb; 49(2):257-60. PubMed ID: 23720194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two Cases of Facioscapulohumeral Muscular Dystrophy 2 in Korea.
    Lee JH; Park HJ; Seong MW; Park SS; Choi YC
    Yonsei Med J; 2021 Jan; 62(1):95-98. PubMed ID: 33381940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up of MRI changes in thigh muscles of patients with Facioscapulohumeral dystrophy: A quantitative study.
    Fatehi F; Salort-Campana E; Le Troter A; Lareau-Trudel E; Bydder M; Fouré A; Guye M; Bendahan D; Attarian S
    PLoS One; 2017; 12(8):e0183825. PubMed ID: 28841698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FAT1 Gene Alteration in Facioscapulohumeral Muscular Dystrophy Type 1.
    Park HJ; Lee W; Kim SH; Lee JH; Shin HY; Kim SM; Park KD; Lee JH; Choi YC
    Yonsei Med J; 2018 Mar; 59(2):337-340. PubMed ID: 29436205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FSHD1 and FSHD2 form a disease continuum.
    Sacconi S; Briand-Suleau A; Gros M; Baudoin C; Lemmers RJLF; Rondeau S; Lagha N; Nigumann P; Cambieri C; Puma A; Chapon F; Stojkovic T; Vial C; Bouhour F; Cao M; Pegoraro E; Petiot P; Behin A; Marc B; Eymard B; Echaniz-Laguna A; Laforet P; Salviati L; Jeanpierre M; Cristofari G; van der Maarel SM
    Neurology; 2019 May; 92(19):e2273-e2285. PubMed ID: 30979860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy.
    Statland JM; Campbell C; Desai U; Karam C; Díaz-Manera J; Guptill JT; Korngut L; Genge A; Tawil RN; Elman L; Joyce NC; Wagner KR; Manousakis G; Amato AA; Butterfield RJ; Shieh PB; Wicklund M; Gamez J; Bodkin C; Pestronk A; Weihl CC; Vilchez-Padilla JJ; Johnson NE; Mathews KD; Miller B; Leneus A; Fowler M; van de Rijn M; Attie KM
    Muscle Nerve; 2022 Jul; 66(1):50-62. PubMed ID: 35428982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle MRI in Duchenne muscular dystrophy: Evidence of a distinctive pattern.
    Polavarapu K; Manjunath M; Preethish-Kumar V; Sekar D; Vengalil S; Thomas P; Sathyaprabha TN; Bharath RD; Nalini A
    Neuromuscul Disord; 2016 Nov; 26(11):768-774. PubMed ID: 27666775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A quantitative method to assess muscle edema using short TI inversion recovery MRI.
    Dahlqvist JR; Salim R; Thomsen C; Vissing J
    Sci Rep; 2020 Apr; 10(1):7246. PubMed ID: 32350361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing.
    Jones TI; Yan C; Sapp PC; McKenna-Yasek D; Kang PB; Quinn C; Salameh JS; King OD; Jones PL
    Clin Epigenetics; 2014; 6(1):23. PubMed ID: 25400706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic magnetic resonance imaging of muscle contraction in facioscapulohumeral muscular dystrophy.
    Deligianni X; Santini F; Paoletti M; Solazzo F; Bergsland N; Savini G; Faggioli A; Germani G; Monforte M; Ricci E; Tasca G; Pichiecchio A
    Sci Rep; 2022 May; 12(1):7250. PubMed ID: 35508609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five-year follow-up study on quantitative muscle magnetic resonance imaging in facioscapulohumeral muscular dystrophy: The link to clinical outcome.
    Vincenten SCC; Mul K; van As D; Jansen JJ; Heskamp L; Heerschap A; van Engelen BGM; Voermans NC
    J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1695-1706. PubMed ID: 37218549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.